Same Arthritis Drug, Different Results: Why Treatment Nonresponse Is Not Your Fault
If two patients take the exact same medication, why does one recover while the other sees little to no improvement.
Search results for "Bio"
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry of Food and Drug Safety for...
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform,...
Epigenetic Clocks Claiming to Measure Your 'True Age' Still Lack Scientific Standards
"Chronological age: 50s. Body age: 30s." This tagline has long been attached to celebrities praised for their...
Beyond Diseased Samples: National Biobank to Collect Healthy Organ Tissue from Deceased Donors
When a specific gene or protein is expressed at unusually high levels in diseased tissue, determining whether the...
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
Celltrion Secures Dominant Market Share in Asia Led by Autoimmune and Oncology Biosimilars
Celltrion is consolidating its leading market position across major Asian countries with its key autoimmune and...
Global Asset Managers Expand Holdings in South Korean Pharma and Biotech
Major institutional asset managers are steadily increasing their equity stakes in South Korean pharmaceutical and...
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's...
GC Biopharma Develops Advanced Platform to Track mRNA Vaccine Degradation
GC Biopharma has developed a technology platform capable of precisely analyzing how mRNA vaccines degrade when exposed...